Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06614_nanopub.RANZpJ807TCTxraYS_JL8NOAnddBhj9TtDnqCLLroBJhw#assertion>. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB06614 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06614 label "Peramivir [drugbank:DB06614]" assertion.
- drugbank:DB06614 seeAlso DB06614 assertion.
- drugbank:DB06614 identifier "drugbank:DB06614" assertion.
- drugbank:DB06614 description "Peramivir is an experimental antiviral drug being developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir is supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. The drug has had a long history. An oral formulation was abandoned by Johnson and Johnson due to poor bioavailability. BioCryst is now developing a injectable version, in partnership with Green Cross Pharmaceuticals in South Korea and with Shionogi Pharmaceuticals in Japan. The drug is in Phase II studies." assertion.
- drugbank:DB06614 title "Peramivir" assertion.
- drugbank:DB06614 bio2rdf_vocabulary:identifier "DB06614" assertion.
- drugbank:DB06614 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06614 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06614" assertion.
- drugbank:DB06614 bio2rdf_vocabulary:x-identifiers.org DB06614 assertion.
- drugbank:DB06614 drugbank_vocabulary:drugbank-id "DB06614" assertion.
- drugbank:DB06614 drugbank_vocabulary:x-cas cas:229614-55-5 assertion.
- drugbank:DB06614 drugbank_vocabulary:x-chemspider chemspider:133234 assertion.
- drugbank:DB06614 drugbank_vocabulary:x-pubchemcompound pubchem.compound:151164 assertion.
- drugbank:DB06614 drugbank_vocabulary:x-wikipedia wikipedia:Peramivir assertion.
- drugbank:DB06614 drugbank_vocabulary:x-bindingdb bindingdb:50092139 assertion.